Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin Lymphoma

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore

Northside Hospital, Atlanta

Moffitt Cancer Center, Tampa

University of Alabama at Birmingham Cancer Center, Birmingham

Vanderbilt University/Ingram Cancer Center, Nashville

University of Kentucky/Markey Cancer Center, Lexington

Ohio State University Comprehensive Cancer Center, Columbus

Wayne State University/Karmanos Cancer Institute, Detroit

University of Wisconsin Carbone Cancer Center - University Hospital, Madison

University of Kansas Cancer Center, Kansas City

University of Kansas Clinical Research Center, Fairway

University of Kansas Hospital-Westwood Cancer Center, Westwood

UT Southwestern/Simmons Cancer Center-Dallas, Dallas

Los Angeles General Medical Center, Los Angeles

USC / Norris Comprehensive Cancer Center, Los Angeles

City of Hope Comprehensive Cancer Center, Duarte

Keck Medical Center of USC Pasadena, Pasadena

UC San Diego Moores Cancer Center, La Jolla

University of California Davis Comprehensive Cancer Center, Sacramento

Smilow Cancer Center/Yale-New Haven Hospital, New Haven

Yale University, New Haven

Massachusetts General Hospital Cancer Center, Boston

Beth Israel Deaconess Medical Center, Boston

Dana-Farber Cancer Institute, Boston